Literature DB >> 24411911

Gap between clinical guidelines and practice: the case of aldosterone-antagonists in patients with myocardial infarction.

Supriya Shore1, Thomas M Maddox2, Fengming Tang3, Philip G Jones3, David E Lanfear4, P Michael Ho2.   

Abstract

Entities:  

Keywords:  Aldosterone antagonist; Clinical guidelines and practice; Myocardial infarction

Mesh：

Substances：

Year:  2013        PMID： 24411911      PMCID： PMC3944131          DOI： 10.1016/j.ijcard.2013.12.076

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  9 in total

1.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Jacqueline E Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal:  Circulation       Date:  2012-12-17       Impact factor: 29.690

2.  The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)--evaluating the impact of myocardial infarction on patient outcomes.

Authors:  John A Spertus; Eric Peterson; John S Rumsfeld; Philip G Jones; Carole Decker; Harlan Krumholz
Journal:  Am Heart J       Date:  2006-03       Impact factor: 4.749

3.  The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes.

Authors:  Matthew T Roe; Eric D Peterson; L Kristin Newby; Anita Y Chen; Charles V Pollack; Ralph G Brindis; Robert A Harrington; Robert H Christenson; Sidney C Smith; Robert M Califf; Eugene Braunwald; W Brian Gibler; E Magnus Ohman
Journal:  Am Heart J       Date:  2006-06       Impact factor: 4.749

4.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

5.  Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry.

Authors:  Suzanne V Arnold; Paul S Chan; Philip G Jones; Carole Decker; Donna M Buchanan; Harlan M Krumholz; P Michael Ho; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-07

6.  Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.

Authors:  David N Juurlink; Muhammad M Mamdani; Douglas S Lee; Alexander Kopp; Peter C Austin; Andreas Laupacis; Donald A Redelmeier
Journal:  N Engl J Med       Date:  2004-08-05       Impact factor: 91.245

7.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  J Am Coll Cardiol       Date:  2007-08-14       Impact factor: 24.094

8.  Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction.

Authors:  Andrew N Rassi; Matthew A Cavender; Gregg C Fonarow; Christopher P Cannon; Adrian F Hernandez; Eric D Peterson; W Frank Peacock; Warren K Laskey; Sylvia E Rosas; Xin Zhao; Lee H Schwamm; Deepak L Bhatt
Journal:  J Am Coll Cardiol       Date:  2012-11-05       Impact factor: 24.094

Review 9.  Medication adherence and the patient with coronary artery disease: challenges for the practitioner.

Authors:  Thomas M Maddox; P Michael Ho
Journal:  Curr Opin Cardiol       Date:  2009-09       Impact factor: 2.161
  9 in total
  1 in total

1.  New treatments for hyperkalaemia: clinical use in cardiology.

Authors:  Shilpa Vijayakumar; Javed Butler; Stefan D Anker
Journal:  Eur Heart J Suppl       Date:  2019-02-26       Impact factor: 1.803
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.